MAP2K7 and melanoma: Amiloride treatment (20 mg kg−1 body mass per day) phenocopied the effects of digitoxin plus MEK inhibitor, significantly reducing intracellular pH (Fig. 4e) and increasing cell death (Fig. 4f) in both melanoma lines, although not to the extent of digitoxin plus MEK inhibitor.